NVO FY 2009 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

FY 2009 Earnings

Reported December 30, 2009

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2009	Prior Q	FY 2008	QoQ Change	YoY Change
Revenue	$8.0B	—	$7.2B	—	11.9%
Op. Income	$2.3B	—	$1.9B	—	20.4%
Gross Margin	79.6%	—	77.8%	—	1.8pp
Net Margin	21.1%	—	21.2%	—	-0.1pp
EPS (Diluted)	$0.28	—	$0.24	—	14.8%
Free Cash Flow	$1.9B	—	$1.7B	—	13.4%

Revenue Flow

Item	Amount
REVENUE	$8.0B
Cost of Revenue	$1.6B
GROSS PROFIT	$6.4B
R&D Expenses	$1.2B
Selling & Marketing	$2.4B
General & Administrative	$434M
SG&A Expenses	$2.9B
Other Expenses	-$54M
Operating Expenses	$4.0B
Cost & Expenses	$5.7B
OPERATING INCOME	$2.3B
Interest Income	$59M
Interest Expense	$198M
Other Income/Expenses	-$148M
INCOME BEFORE TAX	$2.2B
Income Tax Expense	$505M
Net Income from Continuing Ops	$1.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.7B
D&A	$400M
EBIT	$2.4B
EBITDA	$2.8B
EPS	$0
EPS Diluted	$0

Income Statement

Item	Amount
REVENUE	$8.0B
Cost of Revenue	$1.6B
GROSS PROFIT	$6.4B
R&D Expenses	$1.2B
Selling & Marketing	$2.4B
General & Administrative	$434M
SG&A Expenses	$2.9B
Other Expenses	-$54M
Operating Expenses	$4.0B
Cost & Expenses	$5.7B
OPERATING INCOME	$2.3B
Interest Income	$59M
Interest Expense	$198M
Other Income/Expenses	-$148M
INCOME BEFORE TAX	$2.2B
Income Tax Expense	$505M
Net Income from Continuing Ops	$1.7B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.7B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.7B
D&A	$400M
EBIT	$2.4B
EBITDA	$2.8B
EPS	$0
EPS Diluted	$0

Cash Flow Statement

Item	Amount
Net Income	$1.7B
Depreciation & Amortization	$400M
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$358M
Change in Working Capital	-$35M
OPERATING CASH FLOW	$2.4B
Capital Expenditure	-$481M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$3M
NET CASH FROM INVESTING	-$478M
Net Debt Issuance	$0
Common Stock Repurchased	-$1.0B
Common Dividends Paid	-$573M
Other Financing Activities	$0
NET CASH FROM FINANCING	-$1.6B
FREE CASH FLOW	$1.9B
Net Change in Cash	$362M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.8B
Short-Term Investments	$240M
Net Receivables	$1.4B
Inventory	$1.6B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$5.1B
PP&E (Net)	$3.0B
Goodwill	$0
Intangible Assets	$163M
Long-Term Investments	$28M
Tax Assets	$228M
Other Non-Current Assets	$29M
TOTAL NON-CURRENT ASSETS	$3.5B
TOTAL ASSETS	$8.6B
Account Payables	$352M
Short-Term Debt	$66M
Deferred Revenue	$110M
Other Current Liabilities	$1.1B
TOTAL CURRENT LIABILITIES	$2.1B
Long-Term Debt	$152M
Deferred Revenue NC	$72M
Deferred Tax Liabilities	$472M
Other Non-Current Liabilities	$182M
TOTAL NON-CURRENT LIABILITIES	$878M
TOTAL LIABILITIES	$3.0B
Common Stock	$97M
Additional Paid-In Capital	$0
Retained Earnings	$5.5B
Treasury Stock	-$5M
Accum. Other Comp. Income	$0
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$5.6B
Minority Interest	$0
TOTAL EQUITY	$5.6B
TOTAL LIABILITIES & EQUITY	$8.6B
Total Debt	$218M
Net Debt	-$1.6B